Assignment of Assignor's Interest

Recorded: 2022-01-25 Pages: 7

Assignors

BETTENCOURT, BRIAN

Executed: 2013-04-09

FITZGERALD, KEVIN

Executed: 2013-04-09

QUERBES, WILLIAM

Executed: 2013-04-09

Assignee

ALNYLAM PHARMACEUTICALS, INC

300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Properties (2)

Compositions and Methods for Inhibiting Expression of the ALAS1 Gene

Application: 16/893,253 →

Publication: US 2021/0087558

Compositions and Methods for Inhibiting Expression of the ALAS1 Gene

Application: 17/170,648 →

Publication: US 2022/0403382

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.